HOSPICES CIVILS DE LYON
🇫🇷France
Cardiac Repercussion of Systemic Sclerodermias
Not Applicable
Completed
- Conditions
- Systemic Scleroderma
- First Posted Date
- 2008-06-16
- Last Posted Date
- 2019-05-28
- Lead Sponsor
- Hospices Civils de Lyon
- Target Recruit Count
- 148
- Registration Number
- NCT00697736
- Locations
- 🇫🇷
Hôpital Louis Pradel, BRON Cedex, France
Do You Need to Assess Myocardial Ischemia in Type 2 Diabetes
Not Applicable
Terminated
- Conditions
- Type 2 Diabetes
- Interventions
- Other: a bicycle exercise test
- First Posted Date
- 2008-03-03
- Last Posted Date
- 2008-03-03
- Lead Sponsor
- Hospices Civils de Lyon
- Target Recruit Count
- 642
- Registration Number
- NCT00627783
- Locations
- 🇫🇷
Hopital Louis Pradel, Bron, France
GPIIbIIIa Inhibitors in the RESCUe and RESURCOR Networks at the Acute Myocardial Infarction
- First Posted Date
- 2007-10-02
- Last Posted Date
- 2008-11-24
- Lead Sponsor
- Hospices Civils de Lyon
- Target Recruit Count
- 320
- Registration Number
- NCT00538317
- Locations
- 🇫🇷
Hospices Civils de Lyon, Lyon, France
Effect of Prone Positioning on Mortality in Patients With Severe and Persistent Acute Respiratory Distress Syndrome
Not Applicable
Completed
- Conditions
- Acute Respiratory Distress Syndrome
- Interventions
- Procedure: prone position
- First Posted Date
- 2007-09-11
- Last Posted Date
- 2015-05-07
- Lead Sponsor
- Hospices Civils de Lyon
- Target Recruit Count
- 474
- Registration Number
- NCT00527813
- Locations
- 🇫🇷
Hôpital Croix Rousse, Lyon, France
Visual Impairment, Oscillopsia and Multiple Sclerosis
Terminated
- Conditions
- Multiple Sclerosis
- First Posted Date
- 2007-07-09
- Last Posted Date
- 2010-09-30
- Lead Sponsor
- Hospices Civils de Lyon
- Target Recruit Count
- 100
- Registration Number
- NCT00498199
- Locations
- 🇫🇷
Caroline Tilikete, Lyon, France
A Study of Two Associations of Rituximab and Chemotherapy, With a PET-driven Strategy, in Lymphoma
Phase 2
Completed
- Conditions
- Lymphoma, B-CellLymphoma, Large-Cell, Diffuse
- Interventions
- Drug: R-CHOP14 induction regimenDrug: R-ACVBP14 induction regimen
- First Posted Date
- 2007-07-09
- Last Posted Date
- 2014-08-13
- Lead Sponsor
- Hospices Civils de Lyon
- Target Recruit Count
- 222
- Registration Number
- NCT00498043
- Locations
- 🇫🇷
René Olivier Casasnovas, Dijon, France
Clinical Trial on Alzheimer Disease, Presbycusis and Hearing Aids
Not Applicable
Completed
- Conditions
- PresbycusisAlzheimer Disease
- First Posted Date
- 2007-06-19
- Last Posted Date
- 2016-08-30
- Lead Sponsor
- Hospices Civils de Lyon
- Target Recruit Count
- 51
- Registration Number
- NCT00488007
- Locations
- 🇫🇷
Xavier PERROT, Lyon, France
RIBAJUSTE Clinical Trial Investigating the Efficacy and Safety of Dose Adaptation of Ribavirin
Phase 3
- Conditions
- Chronic Hepatitis C
- Interventions
- Drug: Peg-interferon alpha 2a and ribavin
- First Posted Date
- 2007-06-12
- Last Posted Date
- 2012-01-09
- Lead Sponsor
- Hospices Civils de Lyon
- Target Recruit Count
- 236
- Registration Number
- NCT00485342
- Locations
- 🇫🇷
Marianne Maynard, Lyon, France
TETRAM 2. Treatment With Erythropoetin in Patients With Spinal Trauma With Neurological Deficit, Maximum Tolerated Dose Study
Phase 1
Withdrawn
- Conditions
- Spinal Trauma With Neurological Deficit
- First Posted Date
- 2007-05-24
- Last Posted Date
- 2009-03-11
- Lead Sponsor
- Hospices Civils de Lyon
- Target Recruit Count
- 20
- Registration Number
- NCT00478517
Treatment of Myeloma in Patients <= 65 Years Old With Response >= 50% After HSC Autotransplant by Allogenic Transplant Genoidentical or Phenoidentical After Reduced Intensity Conditioning
Phase 2
Completed
- Conditions
- Myeloma
- Interventions
- Drug: reduced intensity conditioning
- First Posted Date
- 2007-04-27
- Last Posted Date
- 2014-01-15
- Lead Sponsor
- Hospices Civils de Lyon
- Target Recruit Count
- 13
- Registration Number
- NCT00466674
- Locations
- 🇫🇷
Mohamad Sobh, Lyon, France
© Copyright 2025. All Rights Reserved by MedPath